369 related articles for article (PubMed ID: 24045940)
21. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
[TBL] [Abstract][Full Text] [Related]
22. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.
Yu Y; Blokhuis BRJ; Diks MAP; Keshavarzian A; Garssen J; Redegeld FA
Front Immunol; 2018; 9():2138. PubMed ID: 30294327
[TBL] [Abstract][Full Text] [Related]
23. Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β
Carroll DJ; O'Sullivan JA; Nix DB; Cao Y; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2018 Jun; 141(6):2196-2207. PubMed ID: 28888781
[TBL] [Abstract][Full Text] [Related]
24. Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.
Kiwamoto T; Katoh T; Evans CM; Janssen WJ; Brummet ME; Hudson SA; Zhu Z; Tiemeyer M; Bochner BS
J Allergy Clin Immunol; 2015 May; 135(5):1329-1340.e9. PubMed ID: 25497369
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
26. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
27. Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
Meril S; Harush O; Reboh Y; Matikhina T; Barliya T; Cohen CJ
Mol Carcinog; 2020 Jul; 59(7):713-723. PubMed ID: 32391973
[TBL] [Abstract][Full Text] [Related]
28. Sialic Acid-Siglec-E Interactions During
Mukherjee K; Khatua B; Mandal C
Front Immunol; 2020; 11():332. PubMed ID: 32184783
[No Abstract] [Full Text] [Related]
29. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.
Brinkman-Van der Linden EC; Varki A
J Biol Chem; 2000 Mar; 275(12):8625-32. PubMed ID: 10722702
[TBL] [Abstract][Full Text] [Related]
30. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
31. Siglec-9 Regulates an Effector Memory CD8
Haas Q; Boligan KF; Jandus C; Schneider C; Simillion C; Stanczak MA; Haubitz M; Seyed Jafari SM; Zippelius A; Baerlocher GM; Läubli H; Hunger RE; Romero P; Simon HU; von Gunten S
Cancer Immunol Res; 2019 May; 7(5):707-718. PubMed ID: 30988027
[TBL] [Abstract][Full Text] [Related]
32. Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages.
Higuchi H; Shoji T; Iijima S; Nishijima K
Biosci Biotechnol Biochem; 2016 Jun; 80(6):1141-8. PubMed ID: 26923638
[TBL] [Abstract][Full Text] [Related]
33. Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment.
van de Wall S; Santegoets KCM; van Houtum EJH; Büll C; Adema GJ
Trends Immunol; 2020 Apr; 41(4):274-285. PubMed ID: 32139317
[TBL] [Abstract][Full Text] [Related]
34. Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Lustig M; Chan C; Jansen JHM; Bräutigam M; Kölling MA; Gehlert CL; Baumann N; Mester S; Foss S; Andersen JT; Bastian L; Sondermann P; Peipp M; Burger R; Leusen JHW; Valerius T
Front Immunol; 2023; 14():1178817. PubMed ID: 37346044
[TBL] [Abstract][Full Text] [Related]
35. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
36. The sialoglycan-Siglec-E checkpoint axis in dexamethasone-induced immune subversion in glioma-microglia transwell co-culture system.
Wielgat P; Czarnomysy R; Trofimiuk E; Car H
Immunol Res; 2019 Oct; 67(4-5):348-357. PubMed ID: 31741237
[TBL] [Abstract][Full Text] [Related]
37. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
[TBL] [Abstract][Full Text] [Related]
38. Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy.
Mori Y; Akita K; Yashiro M; Sawada T; Hirakawa K; Murata T; Nakada H
J Biol Chem; 2015 Oct; 290(43):26125-40. PubMed ID: 26342075
[TBL] [Abstract][Full Text] [Related]
39. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
40. Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells.
Li Q; Ren J; Kufe D
Biochem Biophys Res Commun; 2004 Mar; 315(2):471-6. PubMed ID: 14766232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]